Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 11,326–11,350 of 27,380 studies, newest first · page 454 of 1096.

August 2020 25

  1. 2020-08-06

    Global Brain Involvement in Posterior Cortical Atrophy: Multimodal MR Imaging Investigation

    ✓ Peer-reviewed Brain scans and imaging Brain topography

    Key finding: The visual network-related areas showed reduced connectivity and was correlated to atrophy. +4 more findings

  2. 2020-08-06

    AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State

    ✓ Peer-reviewed Tau biomarkers Journal of geriatric psychiatry and neurology

    Key finding: In the total sample, T-tau and Aβ42/p-tau correlated with the total CAMCOG (P < .01); all biomarkers correlated with memory (P < .001); T-tau correlated with language (P < .01). +2 more findings

  3. 2020-08-05

    Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents

    ✓ Peer-reviewed Brain tissue and pathology Neurology

    Key finding: The overall frequency of LATE-NC in Black and White decedents was similar (40.8% vs 45.4%). +4 more findings

  4. 2020-08-05

    APP-Induced Patterned Neurodegeneration Is Exacerbated by APOE4 in Caenorhabditis elegans

    ✓ Peer-reviewed Genetics G3 (Bethesda, Md.)

    Key finding: Compared to the other variants (APOE2 and APOE3), the ε4 allele of APOE (APOE4) hastens and exacerbates early and late onset forms of AD. +1 more finding

  5. 2020-08-05

    Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: SORL1 is associated with AD in the Hong Kong Chinese population. +4 more findings

  6. 2020-08-04

    Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging

    ✓ Peer-reviewed Brain tissue and pathology Neurology

    Key finding: Compared to those without LATE-NC or ADNC, those with pure LATE-NC had a faster decline in global cognition (p = 0.025) and episodic memory (p = 0.002); however, compared to persons with pure ADNC, those with pure LATE-NC showed a slower decline. +4 more findings

  7. 2020-08-04

    Senolytic drugs: from discovery to translation

    ✓ Peer-reviewed Brain scans and imaging Journal of internal medicine

    Key finding: In preclinical models, senolytics delay, prevent or alleviate frailty, cancers and cardiovascular, neuropsychiatric, liver, kidney, musculoskeletal, lung, eye, haematological, metabolic and skin disorders as well as complications of organ transplantation, radiation and cancer treatment. +4 more findings

  8. 2020-08-04

    Predicting Alzheimer's disease progression using deep recurrent neural networks

    ✓ Peer-reviewed Long-term cohort studies NeuroImage

    Key finding: In this study, given multimodal AD markers and clinical diagnosis of an individual from one or more timepoints, we seek to predict the clinical diagnosis, cognition and ventricular volume of the individual for every month (indefinitely) into the future. +3 more findings

  9. 2020-08-03

    From monomer to fibril: Abeta‐amyloid binding to Aducanumab antibody studied by molecular dynamics simulation

    ✓ Peer-reviewed Treatments Proteins: Structure, Function, and Bioinformatics

    Key finding: In order to better understand how Aducanumab interacts with aggregated A β ‐forms compared to monomers, we have generated structural model complexes based on the known structure of Aducanumab in complex with an A β 2 − 7 ‐eptitope. +1 more finding

  10. 2020-08-03

    Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

    ✓ Peer-reviewed Risk factors The Journal of clinical investigation

    Key finding: Diabetes, obesity, and Alzheimer's disease (AD) are associated with vascular complications and impaired nitric oxide (NO) production. +1 more finding

  11. 2020-08-03

    MicroRNA predicts cognitive performance in healthy older adults

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: A random forest regression combining miRNA with biological (brain volume), clinical (comorbid conditions), and demographic variables in 115 typically aging older adults explained the greatest level of variance in cognitive performance compared to the other machine learning models explored. +1 more finding

  12. 2020-08-03

    The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology

    ✓ Peer-reviewed Down syndrome and Alzheimer's Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: This represents the largest U.S.-based, multi-site, biomarker initiative of AD in DS.

  13. 2020-08-03

    Understanding Medicare: Hearing Loss and Health Literacy

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Medicare beneficiaries with a little or a lot of trouble hearing had 18% (95% confidence interval [CI] odds ratio [OR] = 1.10-1.27) and 25% (95% CI OR = 1.07-1.47) increased odds of reporting greater difficulty with understanding Medicare, respectively, compared with those with no hearing trouble. +2 more findings

  14. 2020-08-03

    Evaluation of Racial Disparities in Hospice Use and End-of-Life Treatment Intensity in the REGARDS Cohort

    ✓ Peer-reviewed Disparities JAMA network open

    Key finding: Black decedents were less likely than White decedents to use hospice for 3 or more days (132 of 378 [34.9%] vs 385 of 834 [46.2%]; P Conclusions and relevance Despite the increase in the use of hospice care in recent decades, racial disparities in the use of hospice remain, especially for noncancer deaths.

  15. 2020-08-03

    Prevention and Management of Delirium in the Intensive Care Unit

    ✓ Peer-reviewed Prevention and risk Seminars in respiratory and critical care medicine

    Key finding: It is associated with increased morbidity and mortality, longer lengths of stay, higher hospital costs, and cognitive impairment that persists long after hospital discharge.

  16. 2020-08-02

    Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics

    ✓ Peer-reviewed Drug development Biochemical pharmacology

    Key finding: The non-acylated and non-PEGylated IRAs (exendin-4, lixisenatide, Peptide 17, DA3-CH and DA-JC4) had significant rates of blood-to-brain influx (Ki), but the acylated IRAs (liraglutide, semaglutide, and Peptide 18) did not measurably cross the BBB.

  17. 2020-08 month only

    A systematic review of the integration of palliative care in dementia management

    ✓ Peer-reviewed End-of-life care Palliative & supportive care

    Key finding: Four key themes were identified in this review: goals of care and end-of-life conversations, symptom management, emergency room visits, and prescribing behavior. +4 more findings

  18. 2020-08-01

    Applying the Health Belief Model to Quantify and Investigate Expectations for Computerized Cognitive Training

    ✓ Peer-reviewed Cognitive tests and assessment Journal of cognitive enhancement : towards the integration of theory and practice

    Key finding: Despite the demonstrated benefits of computerized cognitive training for older adults, little is known about the determinants of training behavior. +2 more findings

  19. 2020-08-01

    The Microbiome as a Modifier of Neurodegenerative Disease Risk

    ✓ Peer-reviewed Disease mechanisms Cell host & microbe

    Key finding: In this review, we discuss roles for the microbiome in aging and in NDs. +4 more findings

  20. 2020-08-01

    Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications

    ✓ Peer-reviewed Drug development BMC complementary medicine and therapies

    Key finding: Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. +1 more finding

  21. 2020-08-01

    Genetic variants and functional pathways associated with resilience to Alzheimer's disease

    ✓ Peer-reviewed Genetics Brain : a journal of neurology

    Key finding: As expected, all resilience metrics were genetically correlated with cognitive performance and education attainment traits (P-values < 2.5 × 10-20), and we observed novel correlations with neuropsychiatric conditions (P-values < 7.9 × 10-4). +4 more findings

  22. 2020-08-01

    Early integration of palliative care in a long-term care home: A telemedicine feasibility pilot study

    ✓ Peer-reviewed End-of-life care Palliative & supportive care

    Key finding: For the 61 residents, the average age of the residents was 87 years, with 61% being female and 69% having dementia as the primary diagnosis. +2 more findings

  23. 2020-08-01

    Advance Care Planning Video Intervention Among Long-Stay Nursing Home Residents: A Pragmatic Cluster Randomized Clinical Trial

    ✓ Peer-reviewed End-of-life care JAMA internal medicine

    Key finding: There was no significant reduction in hospital transfers per 1000 person-days alive in the intervention vs control groups (rate [SE], 3.7 [0.2]; 95% CI, 3.4-4.0 vs 3.9 [0.3]; 95% CI, 3.6-4.1; rate difference [SE], -0.2 [0.3]; 95% CI, -0.5 to 0.2). +2 more findings

  24. 2020-08-01
  25. 2020-08-01

    Is Being Home Good for Your Health? Outcomes of Medicaid Home‐ and Community‐Based Long‐Term Care Relative to Nursing Home Care

    ✓ Peer-reviewed Risk factors Health Services Research

    Key finding: We combine the MAX data with Medicare claims to identify hospital admissions, our main outcome variable, and with state and county data on the percent of individuals receiving HCBS versus nursing home care. +2 more findings

Browse the library by subject, with the full score breakdown →